Hb K-Ibadan [beta 46(CD5)Gly----Glu] in an Italian family

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

ESMO real world data and digital oncology·2026

A fully 3D-printed contoured double passive scattering system for ultra-high-dose-rate irradiations.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026

Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial.

ESMO open·2025

A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Thin segmented silicon detectors for single ion tracking in carbon ion beam therapy: Performance insights.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)].

ESMO open·2024

Metabolomic and Proteomic Profiling of Vaso-Occlusive Crises in Sickle Cell Disease: Current Evidence and Future Perspectives.

Hemoglobin·2026

Evaluation of a Customized RDB-FTH Panel for β-Globin Variants in a Malaysian Tertiary Center.

Hemoglobin·2026

CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia.

Hemoglobin·2026

Genotype-Specific Hematologic Signatures Across α-Globin Defect Categories in α-Thalassemia.

Hemoglobin·2026

Mapping the Management-to-Cure Transition in Thalassemia Research: Semantic Topic Modeling of 17,651 Publications Across Three Decades.

Hemoglobin·2026

Uncovering the True Genotype: Unusually Severe Sickle Cell Disease in a Child with an Initial HbSC Diagnosis.

Hemoglobin·2026

Pain profiles in pancreatic cancer and chronic pancreatitis: a multicenter cross-sectional analysis.

Frontiers in pain research (Lausanne, Switzerland)·2026

The health status of incarcerated people in Canada: a narrative review.

Frontiers in public health·2026

Continuity of Vaccination Across the Life Course: Poland in Comparison with Selected EU/EEA Countries and the United Kingdom.

Vaccines·2026

Development and Initial Validation of a Multidimensional Instrument for Assessing Determinants of HPV Vaccine Readiness and Uptake Among Caregivers in Pakistan: A PLS-SEM Approach.

Vaccines·2026

Vaccination Uptake and Pandemic-Related Healthcare Experiences Among People Living with HIV in Romania: A Cross-Sectional Study.

Vaccines·2026

Decoding the Factors Influencing Parental Vaccine Decision-Making: Insights from Saudi Arabia on COVID-19 Vaccination for Children-Lessons for Future Pandemics.

Vaccines·2026

Related Experiment Videos

Hb K-Ibadan [beta 46(CD5)Gly----Glu] in an Italian family

Related Concept Videos

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

A fully 3D-printed contoured double passive scattering system for ultra-high-dose-rate irradiations.

Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial.

A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients.

Thin segmented silicon detectors for single ion tracking in carbon ion beam therapy: Performance insights.

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)].

Metabolomic and Proteomic Profiling of Vaso-Occlusive Crises in Sickle Cell Disease: Current Evidence and Future Perspectives.

Evaluation of a Customized RDB-FTH Panel for β-Globin Variants in a Malaysian Tertiary Center.

CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia.

Genotype-Specific Hematologic Signatures Across α-Globin Defect Categories in α-Thalassemia.

Mapping the Management-to-Cure Transition in Thalassemia Research: Semantic Topic Modeling of 17,651 Publications Across Three Decades.

Uncovering the True Genotype: Unusually Severe Sickle Cell Disease in a Child with an Initial HbSC Diagnosis.

Pain profiles in pancreatic cancer and chronic pancreatitis: a multicenter cross-sectional analysis.

The health status of incarcerated people in Canada: a narrative review.

Continuity of Vaccination Across the Life Course: Poland in Comparison with Selected EU/EEA Countries and the United Kingdom.

Development and Initial Validation of a Multidimensional Instrument for Assessing Determinants of HPV Vaccine Readiness and Uptake Among Caregivers in Pakistan: A PLS-SEM Approach.

Vaccination Uptake and Pandemic-Related Healthcare Experiences Among People Living with HIV in Romania: A Cross-Sectional Study.

Decoding the Factors Influencing Parental Vaccine Decision-Making: Insights from Saudi Arabia on COVID-19 Vaccination for Children-Lessons for Future Pandemics.

Related Experiment Videos

Hb K-Ibadan [beta 46(CD5)Gly----Glu] in an Italian family

Related Concept Videos

Related Articles